Lung and heart lung transplantation


Published on


Published in: Health & Medicine, Education
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Lung and heart lung transplantation

  1. 1. Lung and heart-lung transplantation Overview of the pathophysiology Since the first human lung transplant was attempted in june 1963 by Hardy and colleagues. Over 8.000 lung and heart-lung transplant procedures have been performed. One-year actuarialsurvival now approaches 75 to 80% after lung transplantation , which compares favorably with the sobering 18 days as witnessed for the initially reported case. Since the introduction during the early 1980s of cyclosporine , a calcineurin inhibitor-type of immunosuppressive medication , lungand heart-lung transplantation have became clinically successful endeavors for myriad end-stage cardiopulmonary diseases. The physiologic responses observed posttransplant , however reflect not the attributes of the allograft lung but rather an admixture of responses as determined by the nature of each patients native lung disease, state of conditioning , and type of transplant procedure ( e.g., single or bilateral lung , heart-lung transplant).furthermore ,potential adverse effects ofimmunosuppressive drugs may affect the physiologic responses to exercise after transplantation .a thorough discussion regarding the clinical management of these complicated patients is beyond the scope of this text ; however ,familiarity with their complex exercise physiology should aid exercise prescription and successful rehabilitation. The type of surgical procedure is determined in light of several key factors:the native cardiopulmonary disease, recipient age,and scarcity of donor the united states , approximately 74.000 patients currently await solid organ transplantion , while nearly 4.000 specifically require either lung or heart –lung organ donation.therefore , single lung transplant(SLT) procedures are frequently pursued for older recipients who suffer from either the spectrumof diseases associated with interstitial pulmonary fibrosis or emphysema.conditions associated with significant pulmonary vascular disease (e.g., primary pulmonary hypertension , eisenmengers complex , sarcoidosis ) may be approached with either single or bilateral lungtransplantation but generally do not require an en bloc heart-lung transplant except in situationsinvolving complex congenital heart disease. Pulmonary diseases characterized by chronic airway suppuration ( e.g., cystic fibrosis, bronchiectasis)require bilateral lung transplantation to thereby eliminate both native lungs that pose a serious risk for posttransplant infection during immunosuppression. The conventional surgical approach to either single or bilateral lung transplantation entails anastomosis of proximal mainstem bronchus (or bronchi,for bilateral),pulmonary artery , and reestablishing pulmonary venous effluent by means of anastomosis of a left atrial “cuff”.SLT isaccomplished via a traditional posterolateral thoracotomy incision , while an extensive transversebilateral anterior thoracosternotomy ( clam shell incision ) is utilized for bilateral grafts. Heart-lung transplantion involves the en bloc implantantion of bilateral lungs and heart via a median sternotomy incision. During these surgical procedures, most centers do not perform revascularization of the bronchial arterial circulationwhile patients are similarly rendered “
  2. 2. extrinsically denervated” from autonomic influences and are devoid of normal pulmonarylymphatic drainage. The physiologic responses observed after transplant, therefore, may be significantly affected by these fundamental physiologic differences. Effects on the exercise responseClinical investigations have suggested the following alterations in function that may impact theexercice response observed posttransplantation: Bronchial hyperresponsiveness to either inhaled methacholine, hypertonic saline aerosol, or exercise has been demonstrated in a significant number of lung transplant recipients . hyperresponsiveness may relate to either extrinsic cholinergic pulmonary denervation or airway inflammation such as during allograft rejection or infection . Abnormal mucociliary clearance may relate to a physical impediment imposed by the bronchial anastomosis. Additionally,studies have suggested bronchial mucosal abnormalities characterized by altered epithelium, decreased ciliary beat frequency , and alteration in mucous theology. Cardiac sympathetic denervation after combined heart-lung transplantation, similar to isolated orthotopic heart transplantation ,can reduce the archieved maximum exercise heart rate, peak oxygen consumption (VO2peak), peak oxygen pulse, and lactate threshold.cardiacreinnervation later occurs in a proportion of such patients and is associated with improved chronotropic and inotropic cardiac responses and enhanced oxygen delivery to exercising skeletal muscles. Altered pulmonary vascular permeability may occur soon after lung transplantation and relate to “ischemia reperfusion” graft injury or, later in their clinical course.during episodes of rejection and associated perivascular inflamamation . physiologic consequences of an increased pulmonary vascular permeability and interstitial edema may include a decline in spirometric indices, increased wasted ventilation, and increased ventilation –perfusion inequality and gas exchange . Altered respiratory pattern(i.e.,disproportionate increase in tidal volume at a reduced respiratory rate).consistent with the absence of vagal –mediated inflation inhibition (hering-breuer reflex),has been detected after combined heart-lung and bilateral lung transplantation .stable heart-lung recipients with normal graft function.however.manifiest an appropriate response of ventilation to exercise or progressive hypercapnia.furthermore. pulmonary denervation does not impede the normal tachypneic response to either an increased elastic impedance or intrinsic pulmonary restriction . by contrast, the hypercapnic ventilation response may appear blunted relatively soon after lung transplantation when specifically performed for end-stage hypercapnic chronic obstructive `pulmonary disease. But
  3. 3. subsequently returns toward normal.further. the detection of inspiratory resistiveloads appears normal after combined heart-lung transplantation .despite theabsence of pulmonary afferent innervations.Abnormal pulmonary function tests are frequently observed after both hear-lungand isolated pulmonary transplantation .heart- lung transplant recipients oftenhave a mild restrictive ventilator defect that may relate to volumetric constraintsof the recipient chest cavity and thoracic musculature. The elastic behavior orpressurevolume relationships after uncomplicated lung transplantation appearrelatively normal.values for vital capacity and maximum expiratory flow rates areexpectedlyless after single(approximately 60% of predicted normal value) versusbilateral or heart-lung transplantation. Effects of exercise training Despite attaining higher spirometric values after single or bilateral lung or combined heart-lung transplantation,cardiopulmonary exercise studies have demonstrated the following: Values forVO2peak (approximately 45-55% of predicted)and maximum work rate in these recipients arre reduced. An abnormally reduced “threshold”forlactate,ventilation ,and standard bicarbonate are observed in association with reduction in maximal tolerable exercise capacity, although this cannot be ascribed to factors such as cardiac dysfunction,anemia,or limitations imposed by pulmonary vasculature or lung mechanics. Quadriceps muscle biopsies and 31P-magnetic resonance spectroscopy after clinical lung transplantation have suggested a decrease in proportion of type I fibers and reduced skeletal muscle oxidative capacity and reduced intracellular pH. No difference has been detected in the activities of glycolytic enzymes, while transplant recipients demonstrate a higher reliance on glycolyticnon-oxidative metabolism . therefore,alteration in fiber proportion and reduced mitochondrial activity may indeed contributed to the exercise limitation witnessed after lung transplantation. Immunosuppressant medications may potentially contribute to an alteration in exercise physiology.systemic glucocorticoids have well- described adverse effects on peripheral skeletal muscle and are commonly administered to patients suffering from a spectrum of pulmonary diseases prior to well as in combination therapies posttransplantation.
  4. 4. Glucocorticoids can induce a selective atrophy of type II fibers:however,because these are the major source for lactate production in exercising skeletal muscle, one would not expect corticosteroids to cause inordinate intracellular acidosis.calcineurin inhibitor-type immunosuppressive medications (e.g.,cyclosporine or tacrolimus) have been shown to inhibit skeletal muscle mitochondrial respiration in vitro and diminish endurance exercise time in rats.the mechanism involved is not entirely clear but may relate to diminished mitochondrial calcium efflux with subsequent mitochondrial impact on fiber size has yet been attributed to cyclosporine.although reduction in capillarity of limb musculature may further contribute to the reduction in aerobic capacity. Lung and heart-lung transplantation: exercise testingmethods measures Endpoints commentsaerobic 12 lead ECG,HR serious •Atrial rrhythmiascycle dysrhytmias common early(ramp protocol BP >2mm ST segment posttransplant .10-15 watts/min; Depressionstaged protocol Respired gas T-wveinversión •Heart-lung25 watts/3min analysis with transplant may bestage) associated with Significant STTreadmill cardiac Blood lactate change( 1 MET/3min denervation.stage) RPE,dyspnea SBP>250mmHg or scales DBP>115mmHg •Lung transplant may be associated (0-10) with absent hering- Pulse oximetry Máximum breuer reflex. or arterial PO2. ventilation VO2peak Very reduced transitional Lactate / thresholds for ventiltory lactate and HCO3. ThresholdEndurance distance Note •Useful measure6min walk vitals,dyspnea in assessing Index,SaO2 at rest stops pretransplant severity of illness and posttransplant progress.Strength • Peak torque • Decreased
  5. 5. Isokinetic/isotoni • Maximun muscle mass/c number of reps force related to corticosteroids.Flexibility •Hip,hamstring,lower • Post-Sit and stretch Back flexibility thoracotomy pain may restrict flexibility.Neuromuscular TremorsGait analysis andBalance possible myopathy with calcineurin inhibitors. • Decreased visual acuity due to cataracts or diabetes.Functional • Perform tests ifSit to stand Clinically indicatedStair climbingliftingMEDICATIONS Many of the following medications are used for either immunosuppression or as prophylaxis to thereby prevent potential posttransplant complications: Calcineurin-inhibitor immunosuppressive medications(e.g.,cyclosporine,tacrolimus), TORinhibitor (e.g., rapamycin ), Antimetabolities(e.g.,azathioprine,methotrexate,mycophenolatemofetil. Loop and thiazide diuretics: may contribute to electrolyte abnormalities and muscle weakness. Antihypertensive medications(e.g., beta blockers, ACE inhibitors,calcium-channel blockers). Antibiotics( e.g., quinolone-type(e.g., ciprofloxacin), trimethoprim sulfamethoxazole,antiviral(e.g.,ganciclovir sodium, acyclovir).MEDICATIONS (CONTINUED)
  6. 6. HMG CoA reductase inhibitor medications(e.g.,”statins”) for hyperlipidemia posttransplant: may cause muscle pain or severe muscle injury with potential kidney failure. Calcineurin inhibitors: may cause tremor , neuropathy or myopathy, electrolyte abnormalities ( decreased magnesium and increased potassium), renal tubular metabolic acidosis,or kidney failure. TOR inhibitors:may cause bleeding tendency (decreased patelets) and hyperlipidemia. Beta blockers: may reduce heart rate response to exercise. Calcium-channel blockers: may cause leg swelling or hypotension. Quinoloneantibiotics:may cause tendinitis and tendon rupture . Antiviral medications: may have associated neurotoxicity. Many medications may cause anemia or leucopenia. The spectrum of adverse medication effects may impact exercise capacity or muscle function. The physiologic different in exercise physiology and aerobic capacity preliminary study after lung transplantation has demonstrated significant benefitsfrom formal exercise conditioning.after a six- week program whereupon training intensity ranged from 30 to 60& of maximum heart rate reserve.improvements were observed in minute ventilation,cardiac reserve, and VO2peak.congruent with these findings,recent studies of similarly immunosuppressed heart transplant recipients have also highlighted the benefits of structured exercise training.therefore to mitigate the potential adverse effects of immunosuppressive medications and the frequent preexistent state of deconditioning. Structured exercise rehabilitation program may offer significant clinical advantages. Management and medications Pulmonary transplantation offers a renewed sense of hope and quality of life for enumerable patients with end-stage cardiopulmonary diseases. Nevertheless,the required chronic immunosuppressive medications represent a double-edged sword after transplant. Although decreasing the incidence of acute graft rejection.such medications may heighten the risk ofdeveloping opportunistic infection, malignancy ,osteoporosis,hypertension,diabetes mellitus , andassociated toxicity. The exercise physiologist should be cognizant of these potential complications and maintain vigilance accordingly.notable complications for the posttransplant patient may include the following:
  7. 7. Acute allograft rejection and dysfunction are often heralded by increseadedsubjective sensation of dyspnea, reduction in spirometricsunction, and gasexchange. Expeditious evaluation of the patient for possible transbronchoscopicbiopsy and therapy is imperative.Pneumonia,although often related to typical community-acquired viral or bacterialinfections, may be attributed to opportunistic or atypical atypical pathogenscaused by chronic immunosuppressive medications.routine patient vaccinationwith polyvalent pneumococcal and annual influenza vaccines are recommended.Systemic hypertension is often related to adverse effects of glucocorticoids andcalcineurin inhibitor-type medications.patients often will requireantihypertensive medications with frequent dosage adjustments. Howeversignificant elevation in blood pressure may indicate a toxic blood level range foreither cyclosporine or tacrolimus versus potential worsening renal functionrelated to these medications.Osteoporosis , related to both systemic glucocorticoids and calcineurin inhibitor-type immunosuppressants, poses a significant risk for vertebral and hip fractureafter transplantation, newer prophylactic strategies for osteoporosis includecalcium supplementation,hormonal replacement therapy,bisphosphonates,as wellas exercise,strength,and balance training.Chronic anemia is usually related to suppression of the bone marrow byimmunosuppressive medications. However, various viral infections(e.g.,parvovirus B19, herpesvirus)may sometimes be responsible.severereductions in hemoglobin concentration may affect the patients peak exercisetolerance and ventilator threshold.Bronchiolitis obliterans syndrome(BOS)or chronic graft rejection represents theachillesheel of lung transplantation and may affect two –thirds of recipients byfive small airway fibrosis and obliteration result in aninexorable decay in lung function over time that frequently is refractory toaugmented immunosuppressive therapies.recurrent respiratory tract infectionsand abnormalities of larger airways (i.e.,bronchiectasis ) frequently ensue.Abnormalities of glucose tolerance and metabolism.related to immunosuppressivemedications,may complicated the clinical course of these patients.excessiveweight gain and potential diabetic complications may be favorably impacted byregular exercise and nutritional counseling.
  8. 8. Lung and heart-lung transplantation: exercise programming Modes goals Intensity/frequency/durati Time to goal on Aerobic Increase VO2peak and THR 60-80% of peak HR Variable,3-12 Large muscle endurance RPE 11- mo (depending activities Increase lactate and 13/20(comfortable pace) on (walking, ventilatory thresholds Monitor dyspnea posttransplant cycling, Decreased sensitivity to 1-2 sessions /day medical/surgical swimming) dyspnea 3-7 days/wk complications) Develop more efficient 20-30 min/session breathing patterns (shorter intermittent Restore ADLs exercise sessions may be necessary initially) Emphasize duration over intensity Strength Increase maximal Low resistance, high reps Variable,3- Free weights number of reps 2-3 days/wk 12mo Isokinetic Increase isokinetic /Isotonic torque/work machines Increased lean body mass Flexibility Increase ROM Daily Stretching Tai chiNeuromuscular Improve gait and Daily Walking and balance balance Decrease muscle exercises weakness and Breathing myopathy exercises Functional Restore ADLs Daily Activity- Return to work specific Improve quality of life exercises Restore sexuality medications Special considerations See exercise RPEanddyspnea are the preferred methods of testing table monitoring intensity. Many clients are unable to achieve a training HR yetdemosntrate physiologic improvement. Musculoskeletal complaints, postsurgical chest wall pain, and osteoporosis are common posttransplant complications Myopathy involving respiratory and peripheral muscles may be related to calcineurin inhibitors and corticosteroid medications.severe muscle pain may
  9. 9. indicate a serious complication of “statin” type lipid- lowering medications. “bronchial hyperresponsiveness”posttransplant may contribute to exercise-related bronchospasms and dyspnea Clients usually respond to exercise optimally in mid to late morning, due to adverse effects(e.g.,nausea,fatigue)of morning medication schedules Avoid extremes in ambient temperature and humidity caused by frequent use of antihypertensive and diuretic medications Supplemental O2 may be required either early posttransplant or subsequent to graft complications New or worsening SaO2 responses to exercise may indicate organ rejection or infection and should be communicated to the transplant team Anxiety,depression,and/or fear are commom effects of dyspnea or medications such as corticosteroidsBronchial anastomosis complications may significantly affect clinical outcomes after lungtransplantation. Fortunately,neither dehiscence nor bronchovascular fistula complicationsare presebtlycommom.however development of bronchial anastomotic stricture orstenosis usually caused by exuberant scar tissue formation may both impair spirometricfunction and the normal”mucociliary escalator”.posttransplant inflammation involvingairway cartilage rings may contribute to bronchomalacia, whereupon dynamic airwaycollapse may limit expiratory flow rates. Potential remedies may include endobronchiallaserphotoresection of granulation tissue and/ or deployment of a bronchial stent tothereby maintain the bronchial lumen.furthermore, localized infections of theanastomosis(e.g.,fungal) may require therapy with systemic or inhaled aerosolantibiotics.bronchoscopic assessment is generally required to establish a definitivediagnosis and ,thus, direct the appropriate therapies. Recommendations for exercise testing The primary objectives for exercise testing are two-fold(1) to assess the severity of exercise impairment prior to organ transplant or determine progression of disease and urgency for transplantation and (2)to characterized exercise limitations posttransplantation .pretransplant assessment of VO2max or 6 min walk distance correlate with severity of illness for cystic fibrosis .for example,and the associated risk of death while awaiting transplantation.posttransplant testing may be valuable in determining whether exercise limitation is related to graft dysfunction,occult cardiac disease , peripheral muscle weakness. Or a persistent state of deconditioning .
  10. 10. During either era,pre-or posttransplantation,the principal objectives for exercise testing are similar (also see the lung and heart-lung transplantation: exercise testing table on page 119): Assess severity of disease or progression Assess maximal physical work capacity and state of aerobic fitness Observed cardiorespiratory and metabolic responses to exercise Observe oxyhemoglobin saturation during exercise Provide a basis for prescribing exercise within safe limits and Assess changes in fitness and cardiorespiratory responses to exercise that occur with disease progression or medical /surgical interventions. Recommendations for exercise programming The principal goals of exercise training, both pre-and posttransplantation,are to improve aerobicfitness and alleviate the sense of dyspnea.exercise prescriptions should be tailored to the type ofnative kung disease, level of patient fitness , and posttransplant allograft spirometric function(see the lung and heart-lung transplantation: exercise programming table on page 12).pretransplantpatients with pulmonary arterial hypertension,for example, may be predisposed to development of right ventricular ischemia , arterial oxygen desaturation,and syncope during exertion.exerciseof moderate intensity ( 60-80% of peak heart rate) should be targeted for approximately 20 to 30 min. beta blockers received posttransplant may limit exercise heart rate response; therefore. Assessment of perceived exertion may be preferable.patients should be encouraged to adopt healhy lifestyle modifications that incorporate aerobic activities.balanced diet, and maintenance of appropriate body weight. Special consideration All patients after organ transplantion and certain patients prior to transplant require chronicimmunosuppression,which poses and increased risk for serious infection. Isolation of such patients from the general population in rehabilitation programs is generally not warranted. Although one should be cognizant of the potential risks for transmission of respiratory pathogens from other clients. Maintaining cleanliness of all exercise equipment and patient avoidance of potential ill contacts during these sessions should be emphasized. Potential for impaired glucose tolerance or systemic hypertension as an adverse effect of immunosuppressive medications should be monitored during exercise and related to the referring physician. significant deterioration in exercise tolerance or arterial oxygen saturation from prior baseline values may represent a harbinger of allograft rejection, cytomegalovirus, or other posttransplant opportunistic infections. such data may be of crucial importance to the organ transplant team in determining the need for expeditious clinical evaluation and bronchoscopic lung biopsy. The clinical value in maintaining excellent lines of communication with the transplant team is of paramount importance.
  11. 11. LUNG TRANSPLANTATION CASE STUDY A 45-year old woman underwent bilateral sequential lung transplantation three years ago for interstitial pulmonary fibrosis complicated by severe secondary pulmonary hypertension withright-sided heart failure. She initially improved quite dramatically with respect to both spirometric lung function and exercise tolerance, and went home (to Kuwait) approximately three months posttransplant on standard triple-drug immunosuppression ( i.e.,cyclosporine,mycophenolatemofetil, and prednisone). She returned for reevaluation complaining of progressive shortness of breath and recurrent respiratory tract infections with methicillin-resistantstaphylococcus aureus and pseudomonas aeruginosa. She also complained of severe low back pain after sustaining a “slip and fall” injury.S: “ icant breathe again, and my back hurts”O: middle-aged woman, on oxygen,breathless and extremely fatigable with minimal exertionBreath sounds:bilateral basilar crackles and musical inspiratory and expiratory rhonchoThoracolumbar spine:midly tender to palpation,with decreased ROM for flexion and extensionNeurologic examination: normalPulse oximetry: 95% arterial oxygen saturation on 3l/min O2 via nasal prongsChest Xrays:bibasilar scarring and probable dilated and thickened larger airways or bronchiectasisSpirometry: significant decreases in FVC and FEV; severe obstructive ventilator defectSpine X rays: multiple compression fractures of T7,T9 and L1Spine MRI scan: no evidence of malignancyA: 1. BOS, or chronic graft rejection 2. Recurrent respiratory tract infection caused by bronchiectasis and recent exacerbation 3. Osteoporosis with multiple vertebral compression fractures 4. Severe exercise intolerance
  12. 12. P: 1. Intravenous antibiotic treatment of current respiratory infection is needed 2. Prescribe aerosolized antibiotic prophylaxis for chronic bronchiectasis 3. Treat osteoporosis pharmacologically 4. Additional immunosuppression to prevent further loss of lung function from chronic rejection(e.g, tacrolimus and methotrexate) is necessary 5. Prescribe outpatient pulmonary rehabilitationExercise program Goals: 1. Improve functional capacity to increase and maintain ADLs 2. Alleviate dyspnea;improve strength and balance/coordination 3. Pulse oximetry during exercise to determine supplemental oxygen requirements mode frequency duration intensity progression aerobic 3days/wk 20-30min/session THR(110 Progress as tolerated contractions/min) over 6-wk program RPE 12/20 Strength ( all 2days/wk 2 sets of<_ 12 To fatigue Add resistance until major muscle reps 12 reps achieves groups) fatigue Flexibility Daily 20-60s/stretch Hold below Maintain discomfort thresholdNeuromuscular Daily Individualized as As tolerated Maintain (walk drills, needed breathing exercises) Functional ( Daily Individualized as As tolerated Gradual over 3-12activity-specific needed mo exercises)Warm-up/ cool- Before and after 10 min RPE<10/20 down each session
  13. 13. Suggested readingsBrings,MS M Fournier D.J ross and M.I. lewis 1998. Cellular adaptations of skeletal muscles tocyclosporine.Journal of applied physiology 84:1967-75.GaroneS and D.J ross 1999 bronchiolitis obliterans syndrome: rewiev of our know ledge andtreatment strategies.current opinion in organ transplantation 4:254-63Grossman.R.F and J.R maurer 1990 pulmonary considerations intransplantation.clinics in chestmedicine 11:2Hokanson, J.F . J.G mercier and G.A brooks.1995 cyclosporine a decreases rat skeletal musclemitochondrial respiration in vitro.american journal of respiratory and critical care medicine151:1848-51Iber.C.Psimon J.B skatrud et al 1995 the breuer-hering reflex in humans: effects of pulmonarydenervation and hypocapnia.american journal of respiratory and critical care medicine 152:217-24Joint statement of the American society for transplant physicians( ASTP)/American thoracic society(ATS)/European respiratory society (ERS)/international society for heart and lung transplantation(ISHLT).1998 international guidelines for the selection of lung transplant candidates.americanjournal of respiratory and critical care medicine 158:339-39Miyoshi S. E.P trulock H-J schaefers et al 1990 cardiopulmonary exercise testing after single anddouble lung transplantation .chest 97:1130-36Ross D.J P.F waters. A .mohsenifar et al 1993. Hemodynamic responses to exercise after lungtransplantation .chest 103:46-53Schwaiblmair M. W von scheidt.P uberfuhr et al 1999. Functional significance of cardiacreinnervation in heart transplant recipients.journal of heart and lung transplantation 18(9):838-45Stiebellehner L. M quittan A end et al. 1998. Aerobic endurance training program improvesexercise performance in lung transplant recipients.chest 113(4):906-12.